Enhabit, Inc. (NYSE:EHAB – Get Free Report) has been given an average rating of “Moderate Buy” by the eight research firms that are covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell rating, one has given a hold rating and six have issued a buy rating on the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $12.10.
Several research firms have recently commented on EHAB. Wolfe Research set a $12.00 price objective on shares of Enhabit in a report on Thursday, January 8th. Deutsche Bank Aktiengesellschaft upgraded shares of Enhabit to a “buy” rating in a research report on Tuesday, January 13th. UBS Group raised Enhabit from a “neutral” rating to a “buy” rating and increased their price target for the stock from $8.50 to $12.00 in a research report on Thursday, January 8th. Citigroup reissued a “buy” rating on shares of Enhabit in a report on Tuesday, December 16th. Finally, Oppenheimer upgraded Enhabit from a “market perform” rating to an “outperform” rating and set a $14.00 target price on the stock in a research note on Thursday, January 22nd.
Get Our Latest Stock Report on Enhabit
Institutional Investors Weigh In On Enhabit
Enhabit Trading Up 1.1%
Enhabit stock opened at $11.15 on Friday. The company has a quick ratio of 1.58, a current ratio of 1.58 and a debt-to-equity ratio of 0.75. Enhabit has a 52 week low of $6.47 and a 52 week high of $11.35. The company has a market capitalization of $564.05 million, a price-to-earnings ratio of -44.58 and a beta of 1.66. The stock has a 50-day moving average price of $9.99 and a 200 day moving average price of $8.63.
Enhabit (NYSE:EHAB – Get Free Report) last issued its quarterly earnings results on Wednesday, November 5th. The company reported $0.17 earnings per share for the quarter, topping the consensus estimate of $0.12 by $0.05. Enhabit had a negative net margin of 1.14% and a positive return on equity of 3.91%. The company had revenue of $263.60 million for the quarter, compared to the consensus estimate of $267.08 million. Sell-side analysts anticipate that Enhabit will post 0.22 EPS for the current year.
About Enhabit
Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.
The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.
Featured Stories
- Five stocks we like better than Enhabit
- NEW LAW: Congress Approves Setup For Digital Dollar?
- The day the gold market broke
- What a Former CIA Agent Knows About the Coming Collapse
- Your Bank Account Is No Longer Safe
- He just nailed another gold prediction …
Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.
